| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/04/1999 | EP0932694A2 Aav4 vector and uses thereof |
| 08/04/1999 | EP0932693A1 Alphavirus-retrovirus vectors |
| 08/04/1999 | EP0932684A2 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 08/04/1999 | EP0538437B1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| 08/04/1999 | CN1224756A New virus-deactivating method |
| 08/03/1999 | US5932476 Cloning of chicken anemia virus DNA |
| 08/03/1999 | US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 08/03/1999 | US5932468 Adding one or more inorganic salts to stabilize protein in solution at ph 10 to 14, incubating mixture; deactivation without denaturing proteins or losing biological activity |
| 08/03/1999 | US5932467 Genetic engineered cell |
| 08/03/1999 | US5932426 Molecular presenting system |
| 08/03/1999 | US5932222 Mutant respiratory syncytial virus (RSV), vaccines containing same and methods of use |
| 08/03/1999 | CA2093335C Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and composition |
| 07/29/1999 | WO1999037333A1 Method for removing and/or inactivating viruses |
| 07/29/1999 | WO1999037327A1 A virus vaccine of enhanced immunogenicity against aujeszky's disease |
| 07/29/1999 | WO1998059063A3 Bovine adenovirus type 3 genome |
| 07/29/1999 | DE19827750C1 Separating human immunodeficiency virus from fluid, useful for lowering HIV virus load in extracorporeal blood |
| 07/29/1999 | DE19802375A1 Removal and/or inactivation of virus in blood products |
| 07/28/1999 | EP0931830A2 Cytopathic viruses for therapy and phophylaxis of neoplasia |
| 07/28/1999 | EP0931159A2 Non-mammalian dna virus having an altered coat protein |
| 07/28/1999 | EP0931158A1 An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| 07/28/1999 | EP0931157A1 Retroviral vectors |
| 07/28/1999 | EP0698093B1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
| 07/28/1999 | CN1224462A Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 07/27/1999 | US5929222 Expression of a foamy virus envelope protein |
| 07/27/1999 | US5928902 Hybrid protein between CS from plasmodium and HBsAg |
| 07/27/1999 | US5928648 Recombinant herpesvirus of turkeys and uses thereof |
| 07/22/1999 | WO1999036545A2 Adenoviral vectors with modified capsid proteins |
| 07/22/1999 | WO1999036511A2 Feline immunodeficiency virus gene therapy vectors |
| 07/22/1999 | WO1999036084A1 Vaccine composition for herpes simplex virus and methods of using |
| 07/22/1999 | WO1999012948A3 Protein-coated polyribonucleic acids, method for the production thereof, and use of the same |
| 07/22/1999 | WO1998044945A9 Non-infectious, protease defective hiv particles and nucleic acid molecules encoding therefor |
| 07/22/1999 | CA2318575A1 Feline immunodeficiency virus gene therapy vectors |
| 07/22/1999 | CA2318439A1 Vaccine composition for herpes simplex virus and methods of using |
| 07/22/1999 | CA2317941A1 Adenoviral vectors with modified capsid proteins |
| 07/21/1999 | EP0929306A1 Method of inhibiting smooth muscle cell proliferation |
| 07/21/1999 | EP0629239B1 Insecticidal toxins from the parasitic wasp bracon hebetor |
| 07/20/1999 | US5925751 Human cytomegalovirus DNA sequences |
| 07/20/1999 | US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology |
| 07/20/1999 | US5925565 Internal ribosome entry site, vector containing it and therapeutic use |
| 07/20/1999 | US5925555 Propagating virus with reverse transcriptase activity in brain cells |
| 07/20/1999 | US5925512 Monoclonal antibody which specifically binds to mutant hepatitis b virus surface antigen ?a? determinant |
| 07/20/1999 | US5925359 European vaccine strains of the porcine reproductive and respiratory syndrome virus |
| 07/20/1999 | US5925358 Insertion of dna into fowlpox virus genome |
| 07/16/1999 | CA2258948A1 Chimeric poxvirus comprising sequences of a vector component |
| 07/15/1999 | WO1999035276A1 Mammalian matrix-type metalloprotease |
| 07/15/1999 | WO1999018216A9 Chimeric vaccine against tick-borne encephalitis virus |
| 07/15/1999 | CA2317696A1 Mammalian matrix-type metalloprotease |
| 07/14/1999 | EP0928203A1 Gene therapy for inhibition of angiogenesis |
| 07/13/1999 | US5922600 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor |
| 07/13/1999 | US5922327 Equine herpes virus glycoproteins |
| 07/13/1999 | US5922326 Attenuated respiratory syncytial virus vaccine compositions |
| 07/13/1999 | US5922315 Adenoviruses having altered hexon proteins |
| 07/13/1999 | US5922278 Method and apparatus for inactivating contaminants in biological fluid |
| 07/13/1999 | CA2015828C Canine corona virus vaccine |
| 07/08/1999 | WO1999033955A1 Preparation of cells for production of biologicals |
| 07/08/1999 | WO1999033862A1 Free solution ligand interaction molecular separation method |
| 07/08/1999 | WO1999018226A3 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 07/07/1999 | EP0927263A1 Recombinase-mediated generation of adenoviral vectors |
| 07/07/1999 | EP0927261A1 Method of producing particles containing nucleic acid sequences in yeast |
| 07/07/1999 | EP0571410B1 Herpes simplex virus-1 deletion variants and vaccines thereof |
| 07/06/1999 | US5919701 Oligonucleotides with activity against human immunodeficiency virus |
| 07/06/1999 | US5919676 Isolated cell concurrently infected with helper adenovirus with packaging signals flanked by recombinase sites and replication/packaging competant helper-dependent vector with deletion to 35,000 base pairs for insertion of exogenous dna |
| 07/06/1999 | US5919625 Detecting rna in test samples; mixing test sample with a nucleic acid standard encapsidated in bacteriophage viral coat protein, isolating and assaying rna, using non-bacteriophage rna standards |
| 07/06/1999 | US5919458 Immunogen comprising particles of non-infectious human immunodeficieny virus having rna packaging defects in physiologically aceptable vehicle |
| 07/06/1999 | CA1340624C Modified vaccinia virus and methods for making and using the same |
| 07/01/1999 | WO1999032648A1 Recombinant rhabdovirus containing a heterologous fusion protein |
| 07/01/1999 | WO1999032647A1 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells |
| 07/01/1999 | WO1999032646A1 Equine infectious anaemia virus (eiav) based |
| 07/01/1999 | WO1999032145A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |
| 07/01/1999 | WO1999025861A3 Adenovirus vectors and method for reducing homologous recombination phenomena |
| 07/01/1999 | WO1999020773A3 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS |
| 07/01/1999 | WO1999010014A3 Receptor-mediated gene delivery using bacteriophage vectors |
| 07/01/1999 | CA2316414A1 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells |
| 07/01/1999 | CA2316321A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |
| 07/01/1999 | CA2315269A1 Equine infectious anaemia virus (eiav) based |
| 06/30/1999 | EP0925360A1 Angiogenic factor and use thereof in treating cardiovascular disease |
| 06/29/1999 | US5916755 Relates to genes which encode novel proteins related to a family of receptor proteins typified by two related membrane spanning tyrosine kinases: the epidermal growth factor receptor, which is encoded by the erbb gene, and the receptor |
| 06/29/1999 | US5916570 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 06/29/1999 | US5916563 Parvovirus protein presenting capsids |
| 06/29/1999 | CA1340617C Expression of hepatitis b s and pres2 protiens in methylotrophic yeasts |
| 06/24/1999 | WO1999031261A1 SELECTIVE KILLING AND DIAGNOSIS OF p53+ NEOPLASTIC CELLS |
| 06/24/1999 | WO1999031257A2 Protein expression in baculovirus vector expression systems |
| 06/24/1999 | WO1999031251A1 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 06/24/1999 | WO1999031250A2 Constitutive expression of non-infectious hiv-like particles |
| 06/24/1999 | WO1999015509A3 Cyclohexyl and heterocyclyl nucleoside derivatives, method for producing these derivatives, and the use of the derivatives and their oligomers or conjugates in pairing and/or testing systems |
| 06/24/1999 | WO1998043668A9 Attenuated respiratory syncytial virus |
| 06/24/1999 | DE19755035A1 New water-soluble derivatives of antiviral flavonoid compounds, especially 3-methyl-quercetin, useful as antiviral agents |
| 06/24/1999 | CA2635158A1 Protein expression in baculovirus vector expression systems |
| 06/24/1999 | CA2314609A1 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 06/24/1999 | CA2309555A1 Selective killing and diagnosis of p53+ neoplastic cells |
| 06/23/1999 | EP0924298A1 Protein expression in baculovirus vector expression systems |
| 06/22/1999 | US5914260 Fish pancreatic disease virus |
| 06/17/1999 | WO1999029723A1 Recombinant nodavirus compositions and methods |
| 06/17/1999 | WO1999018216A3 Chimeric vaccine against tick-borne encephalitis virus |
| 06/17/1999 | WO1999013064A3 Viral infection of cells using viral vectors |
| 06/17/1999 | WO1999011763A9 Method for purifying and concentrating aav-2 and antigen portions thereof |
| 06/17/1999 | WO1998056919A3 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/16/1999 | EP0922105A2 Infectious papillomavirus pseudoviral particles |
| 06/16/1999 | EP0922092A1 Method of attenuating viruses |
| 06/16/1999 | EP0640128B1 Attenuated respiratory syncytial virus vaccine compositions |